Iofina reports record year as CEO discusses results with Zak Mir

Iofina reports record year as CEO discusses results with Zak Mir

From Share Talk LTD by Share Talk LTD

May 14, 2026 · 8 min

About this episode

Zak Mir interviews Dr Tom Becker about Iofina's record financial results and growth strategy.

Zak Mir talks to Dr Tom Becker, President & CEO, Iofina , in the wake of the specialists in the exploration and production of iodine and manufacturers of speciality chemical products, announcing its audited full-year results for the 12 months to 31 December 2025. This included another record year: Production up 17%, Revenue up 22% and Adjusted EBITDA up 56%. Iofina has been quietly doing the hard yards for years, and the market is now starting to pay attention. Following its audited full-year 2025 results, the specialist iodine producer and chemical products business reported another record year, with production up 17% , revenue up 22% and adjusted EBITDA up 56% . That is the headline. The more interesting story sits underneath it: a company that has executed a very specific growth plan, built capacity at pace, and is now looking to accelerate again. At the centre of that story is a simple idea. Iofina operates in a niche market, but one with critical end uses, steady demand, and room for disciplined expansion. For a business still valued at under £100 million, that combination is understandably beginning to attract attention. Iodine is niche, but it matters more than most…

People in this episode

Host: Zak Mir

Guest: Dr Tom Becker

Topics covered

  • iodine production
  • financial results
  • business growth
  • chemical products
  • market analysis

Keywords

  • Iofina
  • iodine
  • financial results
  • business growth
  • chemical products
  • market demand

Mentioned in this episode

Organizations: Iofina

More episodes of Share Talk LTD

Explore listener stats, chart rankings, contacts and more on the Share Talk LTD podcast page.